MedTrace Logo

Cardiac 3D MRI in Pediatric Cancer Patients

NCT02130934 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-11-15

No results posted yet for this study

Summary

This is a non-randomized prospective pilot study in a single academic center with historic controls. This study will compare Cardiac Magnetic Resonance Images (MRI) of patients who have undergone childhood cancer treatment that has cardio-toxic effects to historic controls. The ultimate goal of this study is to develop a safe and effective method for early diagnosis of heart problems in children who are receiving chemotherapy treatments that may be toxic to the heart.

Conditions

  • Childhood Cancer

Interventions

PROCEDURE

Cardiac 3D MRI

Sponsors & Collaborators

  • Majd Makhoul

    lead OTHER

Principal Investigators

  • Majd Makhoul, MD · University of Kentucky

Eligibility

Min Age
8 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02130934 on ClinicalTrials.gov